First New Lupus Drug in a Half-Century Approved

The FDA has approved belimumab (Benlysta) to treat patients with systemic lupus erythematosus who are already receiving standard treatment. Belimumab, a fully human monoclonal antibody that targets the B-lymphocyte stimulator protein, is the first new lupus therapy in...

Finally, Evidence That Sunscreen Delivers

Primary melanomas developed less often with daily, rather than discretionary, sunscreen use. Routine sunscreen for melanoma prevention is a recommendation almost written in stone. Sunburns are associated with melanoma risk, and sunscreens were designed to minimize...

Which Patients Are Fit to Drive After a Stroke?

The pertinent issue may be not which patients are likely to fail a road test, but rather who should take the test in the first place. What are the best clinical predictors of passing a road test after a stroke? To find out, investigators conducted a literature search...

Updated Guidelines on Secondary Stroke Prevention

An update of the American Heart Association/American Stroke Association guidelines incorporates several lines of new evidence. About one in four strokes that occur annually are recurrent events. The American Heart Association/American Stroke Association has now...